ArticleNPJ breast cancer2024

Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade.

M C Liefaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.